Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CLDX
HRMY
Add up to 3 more stocks
CLDX
Celldex Therapeutics, Inc.
-4.86%
$31.00-1.59Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.06B
52W Range
$22.10 - $45.14
HRMY
Harmony Biosciences Holdings, Inc.
-1.40%
$39.36-0.56Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.28B
52W Range
$25.52 - $43.49
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 12.78 |
| Forward P/E | N/A | 9.98 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.89 | 2.28 |
| P/S Ratio | 18419.87 | 2.37 |
| P/FCF Ratio | N/A | 6.42 |
| EV/EBITDA | N/A | 7.36 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 75.4% |
| Operating Margin | -19160.0% | 24.0% |
| Net Margin | -268385.7% | 18.9% |
| ROE | -42.1% | 18.1% |
| ROA | -38.4% | 13.2% |
| ROIC | -45.2% | 15.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 11.82 | 3.48 |
| Quick Ratio | 11.82 | 3.45 |
| Debt/Equity | 0.01 | 0.15 |
| Interest Coverage | N/A | 14.23 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.